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Background: In 2010, there were approximately 8.8 million incident cases of tuberculosis (TB) worldwide. The
treatment of TB is at least six months long and may be complicated by a high pill burden. In addition, TB patients
often do not take their medication on schedule simply because they forget. Mobile phone text messaging has the
potential to help promote TB treatment adherence. We, therefore, propose to conduct a review of current best
evidence for the use of mobile phone text messaging to promote patient adherence to TB treatment.
Methods: This is a systematic review of the literature. We will preferably include randomized controlled trials (RCTs).
However, non-randomized studies (NRS) will be considered if there is an inadequate number of RCTs.
We will search PubMed, EMBASE, CINAHL, CENTRAL, Science Citation Index, Africa-Wide Information, and WHOLIS
electronic databases for eligible studies available by 30 November 2012 regardless of language or publication
status. We will also check reference lists for additional studies, identify abstracts from conference proceedings and
communicate with authors for any relevant material.
At least two authors will independently screen search outputs, select studies, extract data and assess the risk of bias
(using separate criteria for RCTs and NRS); resolving discrepancies by discussion and consensus. We will assess
clinical heterogeneity by examining the types of participants, interventions and outcomes in each study and pool
studies judged to be clinically homogenous. We will also assess statistical heterogeneity using the chi-square test of
homogeneity and quantify it using the I-square statistic. If study results are found to be statistically homogeneous
(that is heterogeneity P > 0.1), we will pool them using the fixed-effect meta-analysis. Otherwise, we will use
random-effects meta-analysis. We will calculate risk ratios and their corresponding 95% confidence intervals for
dichotomous outcomes, and mean differences for continuous outcomes. For other outcomes without quantitative
data, a descriptive analysis will be used.
Discussion: Our results can be used by researchers and policy-makers to help inform them of the efficacy of
mobile phone text messaging interventions to promote patient adherence to TB treatment.
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Tuberculosis (TB) is a major public health concern, with
an estimated 8.8 million incident cases and 1.7 million
deaths each year worldwide [1,2]. The burden of TB is
highest in 22 low- and middle-income countries, mostly
located in sub-Saharan Africa, where TB is fuelled by the
HIV/AIDS epidemic [2].
The World Health Organization (WHO) guidelines for
TB treatment recommend a directly observed treatment
short course (DOTS) strategy to monitor patient adher-
ence to medication [1,3]. This strategy includes treating
TB using standardized rifampicin-based regimens of six
months duration for new TB cases and eight months for
retreatment cases. Failure of patients to complete TB
treatment results in infectivity, drug resistance, relapse
and death [4]. It is therefore important to find better
ways of improving patient adherence to TB treatment.
A variety of factors may impact on patient adherence to
medication, and thus efforts to improve medication adher-
ence in general are more effective when they address mul-
tiple dimensions of adherence behaviours rather than
single-target interventions [5,6]. Several strategies promot-
ing TB medication adherence have been investigated.
These include interventions promoting better health care
provider-patient communication about adherence; devel-
oping or improving existing adherence support services
that are offered by a multidisciplinary team (nurse, phys-
ician, pharmacy, patient et cetera) [6]; directly observed
therapy (involving a health care worker, community care
worker or family member directly monitoring patients as
they swallow their TB medication) [4]; staff motivation and
supervision [4]; education and counseling [7]; reminder
systems and late patient appointment tracers to help
patients keep appointments [8]; incentives and enablers
[9]; contracts or written or verbal agreements to return for
an appointment or course of treatment; social support pro-
vided by community health care workers [10]; social sup-
port offered to family members to assist the patient in
being adherent, and social support provided by other
patients and support groups [6]. These interventions or
complex combinations of the interventions may need to be
employed to promote TB medication adherence.
Mobile phone text messaging, using the short messaging
service (SMS), has recently been proposed as a means of
promoting TB medication adherence. The findings may be
applicable to adherence to treatment regimens for other
conditions such as HIV/AIDS [11], diabetes, asthma as
well as cardiovascular disease [12,13]. For promoting ad-
herence to TB treatment, text messages can be sent
weekly or daily to patients to remind them to take their
medication [11,14] through one-way communication or
two-way interactive communication (that is, patients can
receive and reply to messages ) [12,15,16]. Text messages
may also be used to notify health care providers that thepatient has taken their medication [14,17,18]. In addition,
the text message intervention can be delivered alone or
bundled with economic incentives [14,18]. Globally, mo-
bile phone use is rapidly increasing, with an estimated six
billion mobile phone users worldwide at the end of 2011
[5,6]. In particular, mobile phone text messaging has
gained popularity among people living in low- and
middle-income countries [19]. We therefore propose to
conduct a review of the current best evidence for the use
of mobile phone text messaging to promote patient adher-
ence to TB treatment.
Methods
Criteria for considering studies for this review
Type of studies
We will include randomized controlled trials (RCTs).
However, non-randomized studies will be considered if
there is an inadequate number of RCTs.
Types of participants
Participants will be adults (including pregnant women)
or children receiving treatment for TB infection, in any
setting.
Types of interventions
We will include interventions in which mobile phone
text messages are used to promote adherence to TB
treatment. The text messaging needs to be delivered to a
patient with TB, or in the case of an infant or child, to a
caregiver. We also will include studies in which the
intervention is compared to no intervention, or to other
interventions for promoting adherence. We will exclude:
studies in which mobile phone voice speaking or voice
messaging are interventions; studies in which the use of
a beeper or pager is the intervention; studies in which
the use of multimedia messaging service is the interven-
tion, and studies in which text messages are bundled
with other interventions, unless it is possible to separate
the effects of text messaging alone.
Types of outcome measures
Primary outcomes The primary outcomes are as follows:
treatment adherence; TB cure; successful completion of
TB treatment, and development of drug resistance.
Secondary outcomes The secondary outcomes are: ex-
posure to stigma associated with TB as a result of the
SMS revealing the patients disease status, and patient
satisfaction with the SMS intervention.
Search methods for identification of studies
A comprehensive and exhaustive search will be performed
by MN with the help of the University librarian, to identify
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regardless of language or publication status (published,
unpublished, in press or in progress). We will search both
peer-reviewed journal articles and the grey literature (non-
published, internal or non-reviewed papers, reports).
Database
We will search the following electronic databases: PubMed;
EMBASE; Cochrane Central Register of Controlled Trials
(CENTRAL); ISI Web of Science (Science Citation Index);
Africa-Wide Information, Cumulative Index of Nursing
and Allied Health (CINAHL), and WHO library databases
(WHOLIS). We will use both text words and medical sub-
ject heading (MeSH) terms; for example tuberculosis, pa-
tient compliance, mobile phone, text messaging, text*,
reminder systems, telemedicine, mHealth, eHealth, medi-
cation adherence, and medication compliance. These terms
will be used in varying combinations. The literature search
strategy will be adapted to suit each database. Table 1
shows the main search strategy we will use.
Conference proceedings
We will search the following conference proceedings for
relevant abstracts: The Union World Conference on Lung
Health, Conference of the Union Africa Region, Confer-
ence of the Union Europe Region, Conference of the
Union Latin America Region, Conference of the Union
Middle East Region, Conference of the Union North
America Region, Conference of the Union South-East Asia
Region, Conference of the Union Asia Pacific Region,
South African Tuberculosis Conference, National Confer-
ence on Tuberculosis and Chest Disease (NATCON).
Searching other sources
In the case of unpublished or ongoing studies, we will
search the WHO International Clinical trials Registry Plat-
form, Clinicaltrials.gov, Pan African Clinical Trials Registry
(PACTR), and contact individual researchers working in
the field as well as the following organizations: WHO, The
International Union Against Tuberculosis and Lung dis-
ease (The Union), Centers for Disease Control and Preven-
tion and mHealth Alliance. We will also search the website
of mHealth Alliance and mHealth in the Low Resource
Settings resources database [20] for eligible studies.Table 1 PubMed search strategy, modified as appropriate for
Search PubMed
#1 “tuberculosis”[MeSH] OR “tuberculosis”[tiab]
#2 “cellular phone”[MeSH] OR “reminder systems”[MeSH] OR telemedic
OR text*[MeSH] OR “medical informatics applications”[MeSH] OR SM
“mobile health”[tiab]
#3 “medication adherence” [MeSH] OR “patient compliance”[MeSH] OR
#4 #1 AND #2 AND #3
MeSH, medical subject heading.Reference lists
We will obtain reference lists of relevant studies identi-
fied and the full-text articles reviewed for inclusion in
the review will be checked for additional information.
Data collection and analysis
The methodology for data collection and analysis will be
based on the guidance of the Cochrane Handbook of
Systematic Reviews for Interventions [21].
Selection of studies
We will develop and pilot a screening guide to ensure
that the inclusion criteria are adhered to and consist-
ently applied by all review authors. Two review authors
(MN and CW), working independently, will screen the
titles and abstracts of all studies identified through the
literature searches for eligibility. MN will obtain the full
text of studies deemed potentially eligible. The two
authors (MN and CW) will independently assess the full
text of each article for eligibity, and compare their
results and resolve discrepancies by discussion and con-
sensus, consulting a third author (LGB, RW or GH) to
resolve any persistent disagreements. For all studies
excluded by the assessors we will describe the reasons
for exclusion.
Data extraction and management
References will be managed using Thomson ISI Research-
Soft Endnote 9.0 [22]. Two authors will independently ex-
tract descriptive and outcome data for each included
article using a standardized data collection form, resolving
any discrepancies by discussion and consensus; failing
which, a third author (LGB, GH or RW) will arbitrate. MN
will enter the final data into the Cochrane Collaboration
Review Manager version 5.1 statistical software (http://ims.
cochrane.org/RevMan). CW will cross-check the data
entered to ensure that there are no data entry errors.
Assessment of risk of bias in included studies
Two authors will independently assess the risk of bias in
the included studies. Separate criteria will be used to as-
sess RCTs and non-randomized studies. The criteria
used to assess the risk of bias of in RCTs will be random
sequence generation; allocation concealment; blinding ofuse in the other databases
ine[MeSH] OR “wireless technology”[MeSH] OR “text messaging”[MeSH]
S[tiab] OR MMS[tiab] OR “mobile phone”[tiab] OR mHealth[tiab] OR
adherence [tiab] OR compliance [tiab]
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sors; incomplete outcome data; selective outcome report-
ing; other sources of bias, and overall risk of bias, in
accordance with the methods used by the Cochrane
Collaboration [21]. The criteria used for risk of bias assess-
ment for non-randomized studies will include selection
bias (with regard to comparability of groups, confounding
and adjustment); performance bias (in terms of the fidelity
of the interventions, and quality of the information regard-
ing who received which interventions, including blinding
of study subjects and healthcare providers); detection bias
(regarding unbiased and correct assessment of outcomes,
including blinding of assessors); attrition bias (with regard
to completeness of sample, follow-up and data), and
reporting bias (with regard to publication biases and select-
ive reporting of results) [21]. Studies will be scored as hav-
ing low, high or unclear risk of bias. The two authors will
resolve disagreements in the assessment of risk of bias by
discussion and consensus, consulting a third author to
resolve any persistent disagreements.
Measures of treatment effect
Data analysis will be conducted using the Cochrane Col-
laboration Review Manager version 5.1 statistical software
(http://ims.cochrane.org/RevMan). The outcomes of inter-
est will be either dichotomous or continuous. We will cal-
culate risk ratios and their corresponding 95% confidence
intervals and P-values for dichotomous outcomes, and
mean differences for continuous outcomes.
Dealing with missing data
In cases of missing or incomplete information presented
in the included studies, we shall contact authors for fur-
ther information.
Data synthesis, assessment/investigation of heterogeneity
We will assess clinical heterogeneity by examining types
of participants, interventions and outcomes in each
study. We will pool data only from studies judged to be
clinically homogenous. Statistical heterogeneity in each
meta-analysis will be assessed using the chi-square test
and quantified using the I-squared statistic. If studies are
sufficiently homogenous (in terms of study populations,
interventions and outcomes), then we will pool the data
across studies and estimate summary effect sizes using a
fixed-effect model. Otherwise, we will use the random-
effects model. We will perform subgroup analyses by
intervention subtypes: long versus short messages; daily
versus weekly messages; short weekly messages versus
long weekly messages; short daily messages versus long
daily messages, and two-way interactive communication
versus one-way communication [11,12,15,16]. We will
also stratify analysis by study design (RCTs separate
from non-randomized studies). Finally, we will use thegrading of recommendations assessment, development,
and evaluation (GRADE) approach [23] to assess the
quality of evidence for the effectiveness of the SMS
intervention. This method results in an assessment of
the quality of the body of evidence as high, moderate,
low, or very low. Evidence is considered of high quality
if ‘further research is very unlikely to change our confi-
dence in the estimate of effect; and moderate quality if
‘further research is likely to have an important impact
on our confidence in the estimate of effect and may
change the estimate. Low quality evidence implies that
‘further research is very likely to have an important im-
pact on our confidence in the estimate of effect and is
likely to change the estimate, and very low quality that
‘we have very little confidence in the effect estimate.
Sensitivity analyses
Several sensitivity analyses will be performed: first to de-
termine whether the study design (RCT versus non-
randomized study) could influence the results of the
meta-analysis; second, to evaluate whether the model of
the statistical method (random-effect vs fixed-effect
model) could change the results, and third, to determine
the impact of excluding studies with a high risk bias on
the results, with emphasis on allocation concealment,
blinded outcome assessment, and losses to follow-up
(with a cut off of 25% loss to follow-up).
Presenting and reporting of results
Findings in our systematic review will be presented in
several ways. Flow diagrams will be used to summarise
the study selection process. Funnel plots will be used to
assess publication bias if we identify 10 or more eligible
studies. The kappa statistic [24] will be used to assess
agreements between the full-text screening, data extrac-
tion and risk of bias assessment by the two authors (MN
and CW). GRADE summary of tables of findings, risk of
bias tables or graphs, and forest plots will also be used
where appropriate. The reporting of outcomes without
quantitative data will be descriptive. Lastly, we will pro-
vide a list of excluded studies with reasons for exclusion
Discussion
Expected significance of the study
The findings of this systematic review will have implica-
tions for policy, practice and research. Our results will
provide evidence of whether or not policy makers can
adopt SMS adherence intervention as best practice to be
used alone or in combination with other proven adher-
ence interventions such as DOTs. They will also inform
clinic or hospital managers of how best to use the inter-
vention to promote adherence thereby achieving high cure
rates and low treatment-failure rates among patients while
decreasing the patient load for DOTs staff [25]. The
Nglazi et al. Systematic Reviews 2013, 2:6 Page 5 of 5
http://www.systematicreviewsjournal.com/content/2/1/6systematic review may also identify specific considerations
that would need to be taken into account for future stud-
ies, such as study location; content and timing of mes-
sages; whether or not patients replied to text messages;
how text messages where sent (automated versus manual);
measurement of adherence; variety of text messages sent
(inclusion of jokes or lifestyle tips); duration of the study;
whether or not participants were provided with the mobile
handsets, and and sample size [13].
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